Antibodies for Thermophilic DNA Polymerase Hot Start PCR

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current nucleic acid amplification techniques using thermophilic DNA polymerases face challenges in achieving high sensitivity and yield, particularly in reducing non-specific nucleic acid synthesis at lower temperatures, which affects the specificity and efficiency of PCR reactions.

Innovation Solution

Development of antibodies that bind specifically to thermophilic DNA polymerases, including those with Family B polymerase catalytic domains, 3′ to 5′ exonuclease domains, and sequence non-specific DNA-binding domains, which are used in hot start compositions to enhance reaction specificity and efficiency by inhibiting polymerase activity at lower temperatures and activating it at higher temperatures.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Temperature

If thermophilic DNA polymerases are used in nucleic acid amplification reactions, then the reaction can proceed at high temperatures compatible with thermal denaturation, but non-specific nucleic acid synthesis occurs at lower temperatures reducing reaction specificity

Engineering Contradiction:
Improvereaction temperature compatibilityVSAvoidnon-specific nucleic acid synthesis
Core Design Contradiction:
TemperatureVSObject-affected harmful factors

Solution Approach 1:

The antibody is pre-bound to the DNA polymerase to form an inactive complex before the PCR reaction begins. This preliminary action prevents the polymerase from catalyzing non-specific synthesis at low temperatures. The complex is prepared in advance and only becomes active when heated to the denaturation temperature, at which point the antibody dissociates from the polymerase.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The antibody serves as an intermediary molecule that temporarily binds to the DNA polymerase to inhibit its activity. This intermediary complex allows the polymerase to be transported and handled without being active, and the antibody naturally dissociates when exposed to high temperature, releasing the active polymerase for the amplification reaction.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Object-affected harmful factors

If hot start compositions are used to reduce non-specific synthesis, then reaction specificity improves, but the complexity of the reaction composition increases

Engineering Contradiction:
Improvereaction specificityVSAvoidcomposition complexity
Core Design Contradiction:
Object-affected harmful factorsVSDevice complexity

Solution Approach 1:

The antibody-DNA polymerase complex is designed to be self-regulating through temperature-dependent dissociation. The system automatically activates the polymerase at the appropriate temperature without requiring external control mechanisms or additional reagents. The complex serves its own activation function, eliminating the need for separate activation steps or complex buffering systems.

Inventive Principle:
Principle #25Self-service

3Object-affected harmful factors

If antibodies are added to inhibit polymerase activity at low temperatures, then non-specific synthesis is reduced, but the sensitivity and yield of amplification may be affected

Engineering Contradiction:
Improvenon-specific synthesis reductionVSAvoidamplification sensitivity and yield
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The system exploits the temperature parameter to control antibody-polymerase binding affinity. At low temperatures, the antibody binds tightly to inhibit activity. At high temperatures (above the melting temperature of the antibody-polymerase complex), the binding affinity decreases and the complex dissociates, releasing active polymerase. This parameter change ensures complete activation for high-yield amplification while maintaining inhibition during setup.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The antibodies improve the sensitivity and yield of nucleic acid amplification by reducing non-specific synthesis, increasing the specificity of PCR reactions, and allowing for efficient amplification even at low target nucleic acid concentrations.

Implementation Method 1

antibodies that bind specifically to thermophilic DNA polymerases

Methodology Applied
Scientific EffectAntibody-antigen binding:

Implementation Method 2

DNA polymerases comprise a catalytic domain that extends a 3′ terminus of a DNA strand in a template-dependent manner

Methodology Applied
Scientific EffectDNA polymerization: Enzyme

Implementation Method 3

DNA polymerases can also comprise an exonuclease domain, such as a 3′ to 5′ exonuclease domain. Such an exonuclease domain can reduce the frequency of misincorporation by removing mismatched nucleotides from the 3′ end of a nascent DNA strand

Methodology Applied
Scientific EffectExonuclease activity: Enzyme

Implementation Method 4

Certain artificial DNA polymerases further comprise a sequence non-specific double-stranded DNA (dsDNA) binding domain

Methodology Applied
Scientific EffectDNA-protein binding:

Implementation Method 5

which involves cycles of alternating denaturation and primer annealing and extension. Thermophilic DNA polymerases are resistant to inactivation by high temperatures and so are compatible with thermal denaturation steps

Methodology Applied
Scientific EffectThermal denaturation:

Data Source

PatentUS10273530B2Antibodies that bind thermophilic DNA polymerases
Publication Date: 2019.04.30 THERMO FISHER SCI BALTICS UAB
  • US10273530B2 patent drawing
  • US10273530B2 patent drawing
  • US10273530B2 patent drawing

AI summary

This disclosure relates to antibodies that bind thermophilic family B DNA polymerases. Related uses, methods, and compositions are also provided.